Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | PRKDC | P78527 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13487802 | 1.00 | ALOX5 (0.40) | ALOX5PRKDCPGRMAOBPDK2 | |
| SCHEMBL13487431 | 0.94 | ALOX5 (0.40) | ALOX5PRKDCPGRMAOBPDK2 | |
| SCHEMBL13488111 | 0.93 | ALOX5 (0.43) | ALOX5PRKDCPGRPDK2L3MBTL1 | |
| SCHEMBL12577909 | 0.90 | ALOX5 (0.44) | ALOX5PRKDCPGRPDK2GGPS1 | |
| SCHEMBL13487739 | 0.90 | ALOX5 (0.40) | ALOX5PRKDCPGRGGPS1MEN1 | |
| SCHEMBL13487888 | 0.90 | ALOX5 (0.40) | ALOX5PRKDCPGRPDK2GGPS1 | |
| SCHEMBL13487803 | 0.88 | MAOB (0.35) | MAOBPDK2L3MBTL1TNKSPARP1 | |
| SCHEMBL13488218 | 0.88 | MAOB (0.35) | MAOBPDK2L3MBTL1TNKSPARP1 | |
| SCHEMBL13487854 | 0.88 | MAOB (0.36) | PGRMAOBPDK2L3MBTL1TNKS | |
| SCHEMBL13488258 | 0.88 | MAOB (0.36) | PGRMAOBPDK2L3MBTL1TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | ALOX5 39/4885PRKDC 4345/4885PGR 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.